Hepatitis B is a viral infection that targets the liver, but the liver damage it causes comes not from the virus itself but from your own immune system attacking infected liver cells. The virus can cause a short-term illness that resolves on its own, or it can settle into a lifelong chronic infection that gradually scars the liver and raises the risk of liver cancer. Which outcome you face depends heavily on the age at which you’re infected.
How the Virus Gets Into Liver Cells
The hepatitis B virus (HBV) has a very specific target. It enters liver cells by binding to a receptor those cells use to transport bile salts. Once inside, the virus sheds its outer shell and delivers its DNA into the cell’s nucleus, where it converts into a stable, circular form that acts as a master template. From that template, the cell produces all the components the virus needs to make copies of itself.
New viral DNA is assembled in the cell’s main compartment, packaged into particles, wrapped in an envelope, and released into the bloodstream as fully infectious virus. Some of the newly made DNA also travels back into the nucleus, adding more copies of the master template and deepening the virus’s hold on the cell. In some cases, fragments of viral DNA insert themselves directly into the cell’s own chromosomes, a process that can disrupt normal gene function and, over years, contribute to cancer.
Your Immune System Causes the Damage
HBV does not directly kill the liver cells it infects. Studies in chimpanzees showed that liver cells can be heavily infected with no signs of injury at all, right up until the immune system’s killer T cells arrive. The same pattern appears in people: those in an immune-tolerant phase can carry enormous amounts of virus in their blood while their liver enzymes (a marker of cell damage) remain completely normal. Immunocompromised patients also replicate the virus at high levels without liver injury.
The damage begins when specialized immune cells called CD8 T cells recognize viral proteins on the surface of infected liver cells and kill them directly, triggering a process similar to programmed cell death. Those T cells then recruit waves of additional inflammatory cells into the liver. These secondary responders amplify the destruction, killing both infected and bystander cells. Even platelets play a role, helping immune cells accumulate inside the liver and intensifying inflammation. This immune-driven assault is what produces the symptoms of hepatitis: the fatigue, the jaundice, the elevated liver enzymes your doctor measures on a blood test.
Acute Infection: What It Feels Like
Symptoms typically appear one to four months after exposure, though they can show up as early as two weeks. Not everyone develops noticeable symptoms, but when they occur, the acute phase can include:
- Fatigue and general weakness
- Nausea, vomiting, or loss of appetite
- Pain or discomfort in the upper right abdomen
- Dark urine and pale stools
- Yellowing of the skin and eyes (jaundice)
- Joint pain
Acute hepatitis B lasts less than six months. Most adults recover fully within a few months as the immune system clears the virus and builds lasting antibodies.
Why Age Determines the Outcome
The single biggest factor in whether hepatitis B becomes a lifelong problem is how old you are when you catch it. Adults who are infected develop chronic hepatitis less than 5% of the time. Their mature immune systems mount a strong enough response to eliminate the virus, even though that response causes temporary liver inflammation in the process.
Infants and young children face the opposite odds. About 95% of babies infected at birth or in early childhood develop chronic infection. Their immune systems are not yet developed enough to mount the aggressive T cell response needed to clear the virus, so HBV establishes a permanent foothold in the liver. This is why vaccination at birth is so critical, and why screening every pregnant woman for hepatitis B is standard practice.
What Chronic Hepatitis B Does Over Time
Chronic infection means the virus persists in the liver for years or decades. The master template it creates in the nucleus of liver cells is extremely stable and difficult for the body to eliminate. Over time, the ongoing cycle of immune-driven cell destruction and liver repair leads to fibrosis (scarring). As scar tissue accumulates, it can progress to cirrhosis, where so much of the liver is scarred that it can no longer function properly.
Chronic hepatitis B also raises the risk of liver cancer (hepatocellular carcinoma). In untreated patients without cirrhosis, liver cancer develops at a rate of 0.3% to 0.6% per year. In those who have already developed cirrhosis, the annual rate climbs to 2.2% to 3.7%. Antiviral treatment substantially lowers these numbers but does not eliminate the risk entirely, particularly for people who already have significant scarring. The viral DNA that integrates into liver cell chromosomes can drive cancer development independently of ongoing inflammation.
How Hepatitis B Is Detected
The CDC recommends that every adult aged 18 and older be screened for hepatitis B at least once using a three-part blood test. This triple panel checks for three markers that together reveal whether you’ve never been exposed, are currently infected, have recovered from a past infection, or are immune from vaccination.
The key markers and what they mean:
- HBsAg positive, with antibody to the core antigen: You have an active infection. If a specific subtype of that core antibody (IgM) is present, the infection is acute. If it’s absent, the infection is chronic.
- Anti-HBs positive, with core antibody but no surface antigen: You’ve recovered from a past infection and are immune.
- Anti-HBs positive alone: You’re immune from vaccination.
- All markers negative: You’ve never been infected and are not protected unless you’ve been vaccinated (vaccine may not have produced a response).
Pregnant women should be screened during every pregnancy, preferably in the first trimester. People with ongoing risk factors, including those who inject drugs, men who have sex with men, people born in regions where hepatitis B is common (2% or higher prevalence), and household or sexual contacts of someone with known infection, should be tested periodically.
Reactivation After Apparent Recovery
Even people who appear to have cleared hepatitis B can carry traces of viral DNA in their liver cells for life. Normally, the immune system keeps this residual virus suppressed. But if the immune system is weakened, the virus can reactivate and begin replicating aggressively again, sometimes causing severe or even fatal liver damage.
The highest-risk triggers are treatments that deplete B cells (a type of immune cell), stem cell or organ transplants, and certain cancer therapies. Corticosteroids taken for four weeks or longer at moderate to high doses also carry meaningful risk. Combining multiple immune-suppressing treatments raises the danger further. This is why doctors screen for hepatitis B markers before starting chemotherapy, transplant medications, or other immunosuppressive regimens. People with evidence of current or past infection typically receive preventive antiviral treatment before immunosuppression begins.
Vaccination and Long-Term Protection
The hepatitis B vaccine is one of the most effective tools in preventing the disease. A completed vaccine series stimulates the production of protective antibodies along with memory B cells and specialized helper T cells that persist for decades. Even when measurable antibody levels drop below the threshold traditionally considered protective, those memory cell populations remain capable of mounting a rapid response if the virus is encountered. This means that for most people, a completed vaccine series provides durable, long-lasting immunity without the need for booster doses later in life.